Direct: 405.259.6659
Contact
Areas Of Practice
Tele-Prescribing Controlled Substances post-PHEMay 11, 2023 - 1:25 pm
Summary of Landmark Johnson & Johnson Oklahoma Opioid DecisionSeptember 20, 2019 - 11:40 am
Linkedin Profile
Mary Richard
Direct: 405.259.6659
Mary Richard
maryrichard@healthlawoklahoma.com
Telephone: (405) 812-6055
6608 North Western Avenue #233
Oklahoma City, Oklahoma 73116
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy
NewsOK Q&A: Advance directives provide care guidance for end of life
From NewsOK / by Paula Burkes Published: April 28, 2016 Click to see full story – Advance directives provide care guidance for end of life Q: What should we know about decision-making in the future to care for ourselves? A: The mechanism for providing guidance to your health care professionals and to your family at the end […]
Richard named to Mental Health Association Oklahoma’s Advisory Council
A new opportunity for Attorney Mary Holloway Richard will help her continue her work of increasing visibility of mental health issues in Oklahoma. Richard has joined Mental Health Association Oklahoma’s Advisory Council based in Tulsa, Oklahoma. Partnered with the Homeless Alliance, Mental Health Association Oklahoma has a variety of programs including youth wellness screenings, support groups […]
Health care industry leaders need to understand history of regulations
By Mary Holloway Richard, JD, MPH On March 10th, the industry magazine, Modern Healthcare, posted news hot off the presses that a physician, Dr. Benjamin Chu of Kaiser, has been selected to be the CEO of Memorial Hermann Hospital in Houston. As I read this, I couldn’t help but remember my first job out of graduate […]
NewsOK Q&A: New health measures will require baseline screenings
The Centers for Medicare and Medicaid Services (CMS) released new core quality measures for physicians that will require baseline screenings, more data.
FDA announces multi-step response plan to mitigate abuse of pain killers
In response to criticism that it has been too lenient in approving addictive narcotics and reticent to take action to mitigate abuse and overuse of these painkillers, the FDA announced on Friday a multi-step responsive plan of action.